Aptar Pharma Services, Inc. is a provider of drug delivery systems and related services for the pharmaceutical industry. It specializes in the development and supply of components and technologies used in the administration of medications, including nasal, pulmonary, dermal, and injectable formats. The company operates as part of the AptarGroup ecosystem, focusing on regulatory support, formulation assistance, and manufacturing capabilities that help pharmaceutical partners bring products to market. Its offerings support both branded and generic drug development across global markets.
None yet. When a new project in the record names Aptar Pharma Services as owner, partner or investor, it shows here.
The New Jersey facility can handle, store, manufacture and test controlled substances for inhaled and nasal drug products.
